ROCHESTER, N.Y. – Adarza BioSystems, Inc. announced today that former Roche Molecular Systems CEO, Dr. Heiner Dreismann, an internationally recognized leader in the in vitro diagnostics industry, has joined Adarza’s Board of Directors. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves to commercialize its protein multiplex product platform [...]
Having peered into the high-tech future with confidence, Miller and the Adarza team — CEO Rand Henke and chief operating officer Terry Gronwall — now must deal with the timeless issues of the marketplace.
ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $244,500 Qualifying Therapeutic Discovery Project grant from the Internal Revenue Service to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry bioassay platform to the diagnosis and monitoring of bladder cancer. The Qualifying Therapeutic Discovery Program was enacted as part of the [...]
Adarza Biosystems Awarded Phase II SBIR Grant to Support Environmental Exposure Assessment Product Development
ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $1.8 million Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of blood [...]